Scientific Publications

Lab Publications:

1. Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke. Emil Zeynalov, Susan M. Jones. Neural Regeneration Res., 11(3), Mar 2016.

2. HIF structural subunits are differentially regulated at the gene level after activation of the hypoxic pathway. Novak, Alicia E., Jones, Susan M., and Elliott, J. Paul. In preparation.

3. Continuous IV Infusion is the Choice Treatment Route for Arginine-Vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-Evoked Brain Edema. Zeynalov, Emil, Jones, Susan M. Elliot, J.Paul, JoVE, in publication, 2016.

4. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice. Emil Zeynalov; Susan M. Jones; Jeong-Woo Seo; Lawrence D. Snell; J. Paul Elliott. PLOS One 10(8), e0136121, 2015. http://www.ncbi.nlm.nih.gov/pubmed/26275173

5. Methamphetamine induces the release of endothelin. Seo, Jeong-Woo; Jones, Susan M., Hostetter, Trisha A., Iliff, Jeffrey J., West, G. Alexander. J. Neurosci. Res, DOI 10.1002/jnr.23697, 2015. http://www.ncbi.nlm.nih.gov/pubmed/26568405

6. The Role of HIF in Cobalt-Induced Ischemic Tolerance. Susan M. Jones, Alicia E Novak and J.Paul Elliott. Neuroscience 252:420-430, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23916558

7. Primary culture of cellular subtypes from postnatal mouse for in vitro studies of oxygen glucose deprivation. Jones, Susan M., Novak, Alicia E. and Elliott, J.Paul.  Neurosci Methods, 199:241-248, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21620892?dopt=Citation